Testing Practices for Fungal Respiratory Infections and SARS-CoV-2 among Infectious Disease Specialists, United States

Kaitlin Benedict; Samantha Williams; Susan E. Beekmann; Philip M. Polgreen; Brendan R. Jackson; Mitsuru Toda

doi:10.3390/jof7080605

Journal of Fungi (Jul 2021)

Testing Practices for Fungal Respiratory Infections and SARS-CoV-2 among Infectious Disease Specialists, United States

Kaitlin Benedict,
Samantha Williams,
Susan E. Beekmann,
Philip M. Polgreen,
Brendan R. Jackson,
Mitsuru Toda

Affiliations

Kaitlin Benedict: Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA
Samantha Williams: Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA
Susan E. Beekmann: Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA
Philip M. Polgreen: Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA
Brendan R. Jackson: Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA
Mitsuru Toda: Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA

DOI: https://doi.org/10.3390/jof7080605
Journal volume & issue: Vol. 7, no. 8
p. 605

Abstract

Read online

In an online poll, 174 infectious disease physicians reported that testing frequencies for coccidioidomycosis, histoplasmosis, blastomycosis, and cryptococcosis were similar before and during the COVID-19 pandemic, indicating that these physicians remain alert for these fungal infections and were generally not concerned about the possibility of under-detection.

Published in Journal of Fungi

ISSN: 2309-608X (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Science: Biology (General)
Website: http://www.mdpi.com/journal/jof

About the journal

Abstract

Keywords